143 related articles for article (PubMed ID: 33628006)
1. Exploration of Prognostic Biomarkers among Replication Factor C Family in the Hepatocellular Carcinoma.
Deng J; Zhong F; Gu W; Qiu F
Evol Bioinform Online; 2021; 17():1176934321994109. PubMed ID: 33628006
[TBL] [Abstract][Full Text] [Related]
2. Integrative analysis of expression, prognostic significance and immune infiltration of RFC family genes in human sarcoma.
Wu G; Zhou J; Zhu X; Tang X; Liu J; Zhou Q; Chen Z; Liu T; Wang W; Xiao X; Wu T
Aging (Albany NY); 2022 Apr; 14(8):3705-3719. PubMed ID: 35483337
[TBL] [Abstract][Full Text] [Related]
3. Up-regulated RFC2 predicts unfavorable progression in hepatocellular carcinoma.
Ji Z; Li J; Wang J
Hereditas; 2021 May; 158(1):17. PubMed ID: 34022962
[TBL] [Abstract][Full Text] [Related]
4. CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic Analysis.
Yang WX; Pan YY; You CG
Biomed Res Int; 2019; 2019():1245072. PubMed ID: 31737652
[TBL] [Abstract][Full Text] [Related]
5. CDT1 Is a Novel Prognostic and Predictive Biomarkers for Hepatocellular Carcinoma.
Cai C; Zhang Y; Hu X; Hu W; Yang S; Qiu H; Chu T
Front Oncol; 2021; 11():721644. PubMed ID: 34631549
[TBL] [Abstract][Full Text] [Related]
6. Identification of expression profiles and prognostic value of RFCs in colorectal cancer.
Misbah M; Kumar M; Najmi AK; Akhtar M
Sci Rep; 2024 Mar; 14(1):6607. PubMed ID: 38504096
[TBL] [Abstract][Full Text] [Related]
7. Expression of cell divisioncycle-associated genes and their prognostic significance in hepatocellular carcinoma.
Wang Z; Xu J; Zhang S; Chang L
Int J Clin Exp Pathol; 2021; 14(2):151-169. PubMed ID: 33564348
[TBL] [Abstract][Full Text] [Related]
8. Cell cycle kinases (AUKA, CDK1, PLK1) are prognostic biomarkers and correlated with tumor-infiltrating leukocytes in HBV related HCC.
Islam B; Yu HY; Duan TQ; Pan J; Li M; Zhang RQ; Masroor M; Huang JF
J Biomol Struct Dyn; 2023; 41(21):11845-11861. PubMed ID: 36634158
[TBL] [Abstract][Full Text] [Related]
9. Assessment the value of Pyroptosis-Associated Gasdermin family genes in hepatocellular carcinoma: A Multi-Omics Comprehensive Analysis.
Wei C; Zhou J; Tao W; Qin L; Zhang K; Huang J; Gao L; Zhou S
J Cancer; 2024; 15(7):1966-1982. PubMed ID: 38434972
[No Abstract] [Full Text] [Related]
10. Identification of PLOD Family Genes as Novel Prognostic Biomarkers for Hepatocellular Carcinoma.
Yang B; Zhao Y; Wang L; Zhao Y; Wei L; Chen D; Chen Z
Front Oncol; 2020; 10():1695. PubMed ID: 33014843
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic roles of PRDXs gene family in hepatocellular carcinoma.
Xu M; Xu J; Zhu D; Su R; Zhuang B; Xu R; Li L; Chen S; Ling Y
J Transl Med; 2021 Mar; 19(1):126. PubMed ID: 33771165
[TBL] [Abstract][Full Text] [Related]
12. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
13. Centromere Protein F (
Huang Y; Chen X; Wang L; Wang T; Tang X; Su X
J Cancer; 2021; 12(10):2933-2951. PubMed ID: 33854594
[TBL] [Abstract][Full Text] [Related]
14. The expression and prognostic value of GLYATL1 and its potential role in hepatocellular carcinoma.
Guan R; Hong W; Huang J; Peng T; Zhao Z; Lin Y; Yu M; Jian Z
J Gastrointest Oncol; 2020 Dec; 11(6):1305-1321. PubMed ID: 33457003
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the Expression of
Chen C; Chen S; Pang L; Yan H; Luo M; Zhao Q; Lai J; Li H
Biomed Res Int; 2020; 2020():6412593. PubMed ID: 32104702
[TBL] [Abstract][Full Text] [Related]
16. Systemic Expression Analysis Reveals Prognostic Significance of WIPI3 in Hepatocellular Carcinoma.
Liang TT; Shao Q; Deng ZC; Wang T; Kang QZ
Front Genet; 2020; 11():847. PubMed ID: 32973867
[TBL] [Abstract][Full Text] [Related]
17. Prognostic biomarker SMARCC1 and its association with immune infiltrates in hepatocellular carcinoma.
Cai X; Zhou J; Deng J; Chen Z
Cancer Cell Int; 2021 Dec; 21(1):701. PubMed ID: 34937564
[TBL] [Abstract][Full Text] [Related]
18. Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma.
Huang YL; Ning G; Chen LB; Lian YF; Gu YR; Wang JL; Chen DM; Wei H; Huang YH
Cancer Manag Res; 2019; 11():1725-1740. PubMed ID: 30863181
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma.
Jiang J; Liu B; Liu R; Yang W
Cancer Manag Res; 2021; 13():2517-2537. PubMed ID: 33758547
[TBL] [Abstract][Full Text] [Related]
20.
Lin T; Zhang Y; Lin Z; Peng L
Int J Gen Med; 2021; 14():7487-7501. PubMed ID: 34744456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
